Complex polyamines: Unique prion disaggregating compounds

CNS and Neurological Disorders - Drug Targets

Volumn 8, Issue 5, 2009, Pages 323-328

  Supattapone, Surachai ^a   Piro, Justin R ^a   Rees, Judy R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Branched polyamines; Dendrimers; Prion

Indexed keywords

2,3 DIOLEYLOXY N [2 (SPERMINECARBOXAMIDO)ETHYL] N,N DIMETHYL 1 PROPANAMINIUM TRIFLUOROACETATE; DENDRIMER; LIPOPOLYAMINE DERIVATIVE; PEPTIDE DERIVATIVE; POLYAMIDOAMINE; POLYAMINE DERIVATIVE; POLYETHYLENEIMINE DERIVATIVE; POLYPROPYLENE; POLYPROPYLENEIMINE DERIVATIVE; SPERMINE DERIVATIVE; UNCLASSIFIED DRUG; POLYAMINE; PRION PROTEIN;

DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; HUMAN; LYSOSOME; NONHUMAN; PRION DISEASE; PROTEIN FOLDING; REVIEW; ANIMAL; CATTLE; GOAT; METABOLISM; PRION; SHEEP;

ANIMALS; CATTLE; DENDRIMERS; GOATS; HUMANS; POLYAMINES; PRION DISEASES; PRIONS; PRPC PROTEINS; PRPSC PROTEINS; SHEEP;

EID: 73949154043     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152709789541952     Document Type: Review

References (32)

1. Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. USA, 1998, 95, 13363-13383.
2. Prusiner, S.B. Novel Proteinaceous infectious particles cause scrapie. Science, 1982, 216(4542), 136-144.
3. Castilla, J.; Saa, P.; Hetz, C.; Soto, C. In vitro generation of infectious scrapie prions. Cell, 2005, 121, 195-206.
4. Deleault, N.R.; Harris, B.T.; Rees, J.R.; Supattapone, S. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. USA, 2007, 104, 9741-9746.
5. Taylor, D.M. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet. J., 2000, 159, 10-17.
6. Priola, S.A.; Raines, A.; Caughey, W.S. Porphyrin and phthalocyanine antiscrapie compounds. Science, 2000, 287, 1503-1506.
7. Ludewigs, H.; Zuber, C.; Vana, K.; Nikles, D.; Zerr, I.; Weiss, S. Therapeutic approaches for prion disorders. Expert Rev. Anti Infect. Ther., 2007, 5, 613-630.
8. Mallucci, G.; Dickinson, A.; Linehan, J.; Klohn, P.C.; Brandner, S.; Collinge, J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science, 2003, 302, 871-874.
9. Supattapone, S.; Nguyen, H.O.; Cohen, F.E.; Prusiner, S.B.; Scott, M.R. Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. USA, 1999, 96, 14529-14534.
10. Supattapone, S.; Wille, H.; Uyechi, L.; Safar, J.; Tremblay, P.; Szoka, F.C.; Cohen, F.E.; Prusiner, S.B.; Scott, M.R. Branched polyamines cure prion-infected neuroblastoma cells. J. Virol., 2001, 75, 3453-3461.
11. Winklhofer, K.F.; Tatzelt, J. Cationinc lipopolyamines induce degeneration of PrPSc in scrapie-infected mouse neuroblastoma cells. Biol. Chem., 2000, 381, 463-469.
12. Solassol, J.; Crozet, C.; Perrier, V.; Leclaire, J.; Beranger, F.; Caminade, A.M.; Meunier, B.; Dormont, D.; Majoral, J.P.; Lehmann, S. Cationic phosphorus-containing dendrimers reduce prion repliction both in cell culture and in mice infected with scrapie. J. Gen. Virol., 2004, 85, 1791-1799.
13. Yudovin-Farber, I.; Azzam, T.; Metzer, E.; Taraboulos, A.; Domb, A.J. Cationic polysaccharides as antiprion agents. J. Med. Chem., 2005, 48, 1414-1420.
14. Cordes, H.; Boas, U.; Olsen, P.; Heegaard, P.M. Guanidino- and urea-modified dendrimers as potent solubilizers of misfolded prion protein aggregates under non-cytotoxic conditions, dependence on dendrimer generation and surface charge. Biomacromolecules, 2007, 8, 3578-3583.
15. Griffith, J.S. Self-replication and scrapie. Nature, 1967, 215, 1043-1044.
16. Cohen, F.E.; Pan, K.M.; Huang, Z.; Baldwin, M.; Fletterick, R.J.; Prusiner, S.B. Structural clues to prion replication. Science, 1994, 264, 530-531.
17. Geoghegan, J.C.; Valdes, P.A.; Orem, N.R.; Deleault, N.R.; Williamson, R.A.; Harris, B.T.; Supattapone, S. Selective incorporation of polyanionic molecules into hamster prions. J. Biol. Chem., 2007, 282, 36341-36353.
18. Caughey, B.; Raymond, G.J.; Priola, S.A.; Kocisko, D.A.; Race, R.E.; Bessen, R.A.; Lansbury, P.T., Jr.; Chesebro, B. Methods for studying prion proteins (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update. Mol. Biotechnol., 1999, 13, 45-55.
19. Harris, D.A. Biosynthesis and cellular processing of the prion protein. Adv. Protein Chem., 2001, 57, 203-228.
20. Prusiner, S.B. Prion Biology and Diseases; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, N.Y. 2000.
21. Endo, T.; Groth, D.; Prusiner, S.B.; Kobata, A. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry, 1989, 28, 8380-8388.
22. Locht, C.; Chesebro, B.; Race, R.; Keith, J.M. Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc. Natl. Acad. Sci. USA, 1986, 83, 6372-6376.
23. Stahl, N.; Borchelt, D.R.; Hsiao, K.; Prusiner, S.B. Scrapie prion protein contains a phosphotidylinositol glycolipid. Cell, 1987, 51, 229-240. [24] Turk, E.; Teplow, D.B.; Hood, L.E.; Prusiner, S.B. Purification and properties of a cellular and scrapie hamster prion proteins. Eur. J. Biochem., 1988, 176, 21-30.
24. McKinley, M.P.; Taraboulos, A.; Kenaga, L.; Serban, D.; Stieber, A.; DeArmond, S.J.; Prusiner, S.B.; Gonatas, N. Ultrastructure localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab. Invest., 1991, 65, 622-630.
25. Yang, H.; Kao, W.J. Dendrimers for pharmaceutical and biomedical applications. J. Biomater. Sci. Polym. Ed., 2006, 17, 3-19.
26. Klajnert, B.; Cortijo-Arellano, M.; Cladera, J.; Bryszewska, M. Influence of dendrimer's structure on its activity against amyloid fibril formation. Biochem. Biophys. Res. Commun., 2006, 345, 21-28.
27. Heegaard, P.M.; Boas, U.; Otzen, D.E. Dendrimer effects on peptide and protein fibrillation. Macromol. Biosci., 2007, 7, 1047-1059.
28. Heegaard, P.M.; Pedersen, H.G.; Flink, J.; Boas, U. Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers. FEBS Lett, 2004, 577, 127-133.
29. Breydo, L.; Bocharova, O.V.; Baskakov, I.V. Semiautomated cell-free conversion of prion protein: applications for high-throughput screening potential antiprion drugs. Anal Biochem., 2005, 339, 165-173.
30. Boyd, B.J.; Kaminskas, L.M.; Karellas, P.; Krippner, G.; Lessene, R.; Porter, C.J. Cationinc poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats. Mol. Pharm., 2006, 3, 614-627.
31. Taylor, D.R.; Hooper, N.M. The low-density lipoprotein receptorrelated protein-1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem. J., 2007, 402, 17-23.
32. Parkyn, C.J.; Vermeulen, E.G.; Mootoosamy, R.C.; Sunyach, C.; Jacobsen, C.; Oxvig, C.; Moestrup, S.; Liu, Q.; Bu, G.; Jen, A.; Morris, R.J. LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J. Cell. Sci., 2008, 121, 773-783.